In today’s episode on the Delta Dialog, we investigate the ethical considerations Asimov's laws provoke, the game-changing AI technologies on the horizon for healthcare, the critical role of interdisciplinary partnerships, and the pressing need for a new breed of professionals adept in both AI and medical sciences.

In today’s episode on the Delta Dialog, we look into the nuances of achieving a balance, highlighting key considerations in AI governance, impactful elements of the EU's AI Act for healthcare, and real-world instances where prioritizing effectiveness over mere accuracy proves pivotal in advancing medical AI solutions.

In the second part of our discussion on the webinar we explore key measures that governments can take to ensure the safety of AI. By addressing these aspects, we find that when governments contribute to fostering an AI landscape, it not only thrives on innovation but also upholds ethical principles, accountability, and global cooperation.

Navigating the delicate balance between fostering innovation and addressing potential risks, governments play a crucial role in shaping the responsible development and deployment of AI technologies. Listen with us as we discuss the importance of the role governments play in the AI industry.

Explore the intersection of AI, governance, and global impact through the insights of leading experts in our recent webinar. From the safety of AI to the imperative need for governance and regulation, our distinguished panel delved into crucial topics shaping the future.

AI regulation must be conducive to smarter decision-making, above all in healthcare. Laws cannot just be right, but they must also be effective, says Richard Dasselaar, digital transformation and strategy leader and Section Chairperson for the AI in Cardiology working group as a non-state actor, citing the EU’s newly minted AI Act and several stellar authorities.